Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
GENE:
HGF (Hepatocyte growth factor)
i
Other names:
HGF, DFNB39, F-TCF, HGFB, HPTA, SF, Hepatocyte growth factor (hepapoietin A; scatter factor)
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
3082
Associations
(17)
News
Trials
VERI cancer hierarchy
Reset Filters
HGF elevation + VEGFA elevation
Hepatocellular Cancer
HGF elevation + VEGFA elevation
Hepatocellular Cancer
erlotinib + sorafenib
Resistant: B - Late Trials
erlotinib + sorafenib
Resistant
:
B
erlotinib + sorafenib
Resistant: B - Late Trials
erlotinib + sorafenib
Resistant
:
B
HGF elevation
Hepatocellular Cancer
HGF elevation
Hepatocellular Cancer
cabozantinib tablet
Resistant: B - Late Trials
cabozantinib tablet
Resistant
:
B
cabozantinib tablet
Resistant: B - Late Trials
cabozantinib tablet
Resistant
:
B
HGF elevation
Pancreatic Ductal Adenocarcinoma
HGF elevation
Pancreatic Ductal Adenocarcinoma
Resistant: C3 – Early Trials
Resistant
:
C3
Resistant: C3 – Early Trials
Resistant
:
C3
HGF-L
Non Small Cell Lung Cancer
HGF-L
Non Small Cell Lung Cancer
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
HGF-L
Renal Cell Carcinoma
HGF-L
Renal Cell Carcinoma
pazopanib
Sensitive: C3 – Early Trials
pazopanib
Sensitive
:
C3
pazopanib
Sensitive: C3 – Early Trials
pazopanib
Sensitive
:
C3
HGF expression
Renal Cell Carcinoma
HGF expression
Renal Cell Carcinoma
lenvatinib
Sensitive: C3 – Early Trials
lenvatinib
Sensitive
:
C3
lenvatinib
Sensitive: C3 – Early Trials
lenvatinib
Sensitive
:
C3
HGF amplification
HER2 Positive Breast Cancer
HGF amplification
HER2 Positive Breast Cancer
trastuzumab
Resistant: C3 – Early Trials
trastuzumab
Resistant
:
C3
trastuzumab
Resistant: C3 – Early Trials
trastuzumab
Resistant
:
C3
HGF-L
T Acute Lymphoblastic Leukemia
HGF-L
T Acute Lymphoblastic Leukemia
mogamulizumab-kpkc
Resistant: C3 – Early Trials
mogamulizumab-kpkc
Resistant
:
C3
mogamulizumab-kpkc
Resistant: C3 – Early Trials
mogamulizumab-kpkc
Resistant
:
C3
HGF elevation
Renal Cell Carcinoma
HGF elevation
Renal Cell Carcinoma
pazopanib
Resistant: C3 – Early Trials
pazopanib
Resistant
:
C3
pazopanib
Resistant: C3 – Early Trials
pazopanib
Resistant
:
C3
HGF elevation
Renal Cell Carcinoma
HGF elevation
Renal Cell Carcinoma
sunitinib
Resistant: C3 – Early Trials
sunitinib
Resistant
:
C3
sunitinib
Resistant: C3 – Early Trials
sunitinib
Resistant
:
C3
HGF elevation
Renal Cell Carcinoma
HGF elevation
Renal Cell Carcinoma
sunitinib + pazopanib
Resistant: C3 – Early Trials
sunitinib + pazopanib
Resistant
:
C3
sunitinib + pazopanib
Resistant: C3 – Early Trials
sunitinib + pazopanib
Resistant
:
C3
HGF mutation
Non Small Cell Lung Cancer
HGF mutation
Non Small Cell Lung Cancer
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.